These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 18431226)
1. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. van den Berg-Loonen EM; Billen EV; Voorter CE; van Heurn LW; Claas FH; van Hooff JP; Christiaans MH Transplantation; 2008 Apr; 85(8):1086-90. PubMed ID: 18431226 [TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
3. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay. Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795 [TBL] [Abstract][Full Text] [Related]
4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
5. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch. Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518 [TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Billen EV; Christiaans MH; van den Berg-Loonen EM Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037 [TBL] [Abstract][Full Text] [Related]
8. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Bingaman AW; Murphey CL; Palma-Vargas J; Wright F Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435 [TBL] [Abstract][Full Text] [Related]
9. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? Gupta A; Iveson V; Varagunam M; Bodger S; Sinnott P; Thuraisingham RC Transplantation; 2008 Apr; 85(8):1200-4. PubMed ID: 18431242 [TBL] [Abstract][Full Text] [Related]
10. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487 [TBL] [Abstract][Full Text] [Related]
11. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up. Lachmann N; Terasaki PI; Schönemann C Clin Transpl; 2006; ():171-99. PubMed ID: 18365377 [TBL] [Abstract][Full Text] [Related]
12. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350 [TBL] [Abstract][Full Text] [Related]
13. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients. Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279 [TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant. Claas FH; Doxiadis II Hum Immunol; 2009 Aug; 70(8):636-9. PubMed ID: 19375467 [TBL] [Abstract][Full Text] [Related]
15. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503 [TBL] [Abstract][Full Text] [Related]
16. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development. Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI Clin Transpl; 2006; ():241-53. PubMed ID: 18365382 [TBL] [Abstract][Full Text] [Related]
17. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463 [TBL] [Abstract][Full Text] [Related]
18. Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches. Heidt S; Haasnoot GW; van der Linden-van Oevelen MJH; Claas FHJ Front Immunol; 2021; 12():687254. PubMed ID: 34248971 [TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach. Poli F; Cardillo M; Scalamogna M Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]